IP Library Granted Patent US 12,582,467
Granted Patent B2
US 12,582,467 · App. 18/093,165 · Granted Mar 24, 2026

Surgical instrument with hover sensor and related methods

Inventor: Benjamin D. Dickerson (San Francisco, CA)
Assignee: Cilag GmbH International
A61B18/1492A61B2017/00199A61B2018/00577A61B2018/00696A61B2018/00702A61B2018/00732A61B2018/00761A61B2018/00875A61B2018/00904
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,582,467
App. No.
18/093,165
Granted
Mar 24, 2026
Kind
B2
Abstract

A robotic surgical system, including: a robotic arm including a distal end; a tool driver operatively coupled with the distal end of the robotic arm; a control unit; a surgical instrument including: an end effector configured to transmit therapeutic energy to tissue via a therapeutic energy cycle based on instructions from the control unit; and an tissue sensor configured to determine at least one tissue characteristic and transmit the at least one tissue characteristic to the control unit, wherein the control unit is configured to modify the therapeutic energy cycle based on the at least one tissue characteristic; and a control console including: an activation switch configured to activate the therapeutic energy cycle, and a hover sensor configured to sense an object within a hover zone, wherein the hover sensor is configured to activate the tissue sensor to determine the at least one tissue characteristic.

Claims (43)

1 . A robotic surgical system, comprising:

(a) a robotic arm including a distal end;

(b) a tool driver operatively coupled with the distal end of the robotic arm;

(c) a control unit;

(d) a surgical instrument comprising:

(i) an end effector configured to transmit therapeutic energy to tissue via a therapeutic energy cycle based on instructions from the control unit; and

(ii) an tissue sensor configured to determine at least one tissue characteristic and transmit the at least one tissue characteristic to the control unit, wherein the control unit is configured to modify the therapeutic energy cycle based on the at least one tissue characteristic; and

(e) a control console including:

(i) an activation switch configured to activate the therapeutic energy cycle of the end effector, and

(ii) a hover sensor configured to sense an object proximate to the activation switch within a hover zone, wherein the hover sensor is configured to activate the tissue sensor to determine the at least one tissue characteristic in response to sensing the object within the hover zone.

2 . The robotic surgical system of claim 1 , wherein the tissue sensor comprises an electrical impedance sensing device configured to determine an electrical impedance of the tissue.

3 . The robotic surgical system of claim 1 , wherein the control console comprises a foot control console, wherein the hover sensor is configured to sense a foot of an operator.

4 . The robotic surgical system of claim 3 , wherein the hover zone is positioned at least above the activation switch, the foot control console being configured for the operator to enter the hover zone before activation switch can activate the therapeutic energy cycle of the end effector.

5 . The robotic surgical system of claim 1 , wherein the end effector comprises an electrode configured to deliver RF energy.

6 . The robotic surgical system of claim 1 , wherein the end effector comprises a pair of jaws configured to grasp tissue, wherein the control unit is configured to modify a grasping force of the pair of jaws based on the at least one tissue characteristic.

7 . The robotic surgical system of claim 6 , wherein at least one jaw of the pair of jaws includes an electrode.

8 . The robotic surgical system of claim 7 , wherein the electrode is configured to ablate tissue.

9 . The robotic surgical system of claim 1 , wherein the surgical instrument comprises a robotic interface configured to selectively couple with the tool driver.

10 . The robotic surgical system of claim 9 , wherein the surgical instrument comprises a shaft assembly extending proximally from the end effector.

11 . The robotic surgical system of claim 1 , further comprising a display unit, wherein the display unit is configured to communicate the at least one tissue characteristic determined by the tissue sensor.

12 . The robotic surgical system of claim 1 , wherein the surgical instrument is removably coupled to the robotic arm.

13 . The robotic surgical system of claim 1 , wherein the control unit is configured to modify an intensity of a therapeutic energy cycle based on the at least one tissue characteristic.

14 . The robotic surgical system of claim 1 , wherein the control unit is configured to modify a duration of the therapeutic energy cycle based on the at least one tissue characteristic.

15 . The robotic surgical system of claim 1 , wherein the control unit is configured to modify a frequency of the therapeutic energy cycle based on the at least one tissue characteristic.

16 . The robotic surgical system of claim 1 , wherein the control unit is associated with the control console.

17 . A surgeon console, comprising:

(a) a control unit;

(b) a control console configured to receive commands from an operator and communicate the commands to the control unit;

(c) a robotic arm in communication with the control unit;

(d) a surgical instrument configured to selectively couple with the robotic arm, the surgical instrument comprising an end effector configured to deliver therapeutic energy to tissue, the end effector comprising:

(i) a pair of jaws configured to grasp tissue with an adjustable compression, and

(ii) a tissue sensor configured to determine at least one tissue characteristic and transmit the at least one tissue characteristic to the control unit, wherein the control unit is configured to modify the adjustable compression of the pair of jaws in response to the at least one tissue characteristic; and

(d) a foot control console in communication with the control console and including:

(i) an activation switch configured to activate the end effector with therapeutic energy, and

(ii) a hover sensor configured to sense an object proximate to the activation switch within a hover zone, wherein the hover sensor is configured to activate the tissue sensor to determine the at least one tissue characteristic in response to sensing the object within the hover zone.

18 . A method of activating an end effector, comprising:

(i) receiving indication from a hover sensor that an object has entered a hover zone defined by the hover sensor and positioned proximate to an activation switch;

(ii) in response to receiving indication from the hover sensor, instructing a tissue sensor to determine at least one tissue characteristic of tissue adjacent to the tissue sensor;

(iii) utilizing the at least one tissue characteristic to modify a first therapeutic energy to a second therapeutic energy to be delivered to tissue; and

(iv) receiving indication that activation switch has been pressed; and

(v) activating the end effector with the second therapeutic energy as modified based on at least one tissue characteristic.

19 . The method of claim 18 , wherein the at least one tissue characteristic comprises an electrical impedance.

20 . The method of claim 18 , wherein the hover zone is positioned at least above the activation switch.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2023
From: DICKERSON, BENJAMIN D.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 063450/0047 →
Continuity (1)
Related Publication 20240216044A1 · Jul 4, 2024
References Cited (19)
US 9763741B2 · Alvarez et al. · 2017 [cited by applicant]
US 10166082B1 · Hariri et al. · 2019 [cited by applicant]
US 10464209B2 · Ho et al. · 2019 [cited by applicant]
US RE47996E · Turner · 2020 [cited by examiner]
US 10667875B2 · DeFonzo et al. · 2020 [cited by applicant]
US 10765303B2 · Graetzel et al. · 2020 [cited by applicant]
US 10827913B2 · Ummalaneni et al. · 2020 [cited by applicant]
US 10881280B2 · Baez, Jr. · 2021 [cited by applicant]
US 10888383B2 · Cone et al. · 2021 [cited by applicant]
US 10898277B2 · Srinivasan et al. · 2021 [cited by applicant]
US 11058493B2 · Rafii-Tari et al. · 2021 [cited by applicant]
US 11071595B2 · Johnson et al. · 2021 [cited by applicant]
US 11278361B2 · Gonenc et al. · 2022 [cited by applicant]
US 20090254080A1 · Honda · 2009 [cited by examiner]
US 20190231382A1 · Inoue · 2019 [cited by examiner]
US 20220401143A1 · Sims · 2022 [cited by applicant]
US 20240090962A1 · Itkowitz et al. · 2024 [cited by applicant]
WO WO2021062373A2 · 2021 [cited by examiner]
International Search Report and Written Opinion dated Apr. 29, 2024, for International Application No. PCT/IB2024/050020, 14 pages. [cited by applicant]